Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 29332 | 154 | 36.5 | 92% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | IASPP | Author keyword | 50 | 86% | 16% | 25 |
| 2 | ASPP2 | Author keyword | 35 | 86% | 12% | 18 |
| 3 | 53BP2 | Author keyword | 7 | 67% | 4% | 6 |
| 4 | ASPP | Author keyword | 6 | 53% | 5% | 8 |
| 5 | HEMATOL ONCOL RHEUMATOL IMMUNOL PULMOL | Address | 3 | 57% | 3% | 4 |
| 6 | TP53BP2 | Author keyword | 3 | 100% | 2% | 3 |
| 7 | ASPP1 | Author keyword | 2 | 40% | 3% | 4 |
| 8 | GUANGXI CANC HOSP | Address | 1 | 30% | 2% | 3 |
| 9 | LUDWIG CANC LTD | Address | 1 | 11% | 6% | 9 |
| 10 | CANC AREA CELL THER Y | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | IASPP | 50 | 86% | 16% | 25 | Search IASPP | Search IASPP |
| 2 | ASPP2 | 35 | 86% | 12% | 18 | Search ASPP2 | Search ASPP2 |
| 3 | 53BP2 | 7 | 67% | 4% | 6 | Search 53BP2 | Search 53BP2 |
| 4 | ASPP | 6 | 53% | 5% | 8 | Search ASPP | Search ASPP |
| 5 | TP53BP2 | 3 | 100% | 2% | 3 | Search TP53BP2 | Search TP53BP2 |
| 6 | ASPP1 | 2 | 40% | 3% | 4 | Search ASPP1 | Search ASPP1 |
| 7 | MAOTAI | 1 | 50% | 1% | 1 | Search MAOTAI | Search MAOTAI |
| 8 | MAOTAI LIQUOR | 1 | 50% | 1% | 1 | Search MAOTAI+LIQUOR | Search MAOTAI+LIQUOR |
| 9 | MIR124 | 1 | 50% | 1% | 1 | Search MIR124 | Search MIR124 |
| 10 | P53 BINDING PROTEIN 2 | 1 | 50% | 1% | 1 | Search P53+BINDING+PROTEIN+2 | Search P53+BINDING+PROTEIN+2 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | APOPTOSIS STIMULATING PROTEIN | 42 | 94% | 10% | 15 |
| 2 | 53BP2 | 41 | 81% | 16% | 25 |
| 3 | IASPP | 17 | 75% | 8% | 12 |
| 4 | ASPP | 15 | 82% | 6% | 9 |
| 5 | ASPP1 | 9 | 83% | 3% | 5 |
| 6 | ASPP PROTEINS | 8 | 100% | 3% | 5 |
| 7 | ASPP2 | 7 | 67% | 4% | 6 |
| 8 | P53 INTERACTING PROTEIN 53BP2 | 6 | 100% | 3% | 4 |
| 9 | APOPTOTIC FUNCTION | 5 | 27% | 11% | 17 |
| 10 | ASPP FAMILY | 3 | 100% | 2% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| ASPP: a new family of oncogenes and tumour suppressor genes | 2007 | 89 | 39 | 51% |
| Protein-protein interactions of ASPP2: an emerging therapeutic target | 2014 | 1 | 98 | 53% |
| ASPPs and cancer | 2006 | 65 | 72 | 33% |
| ASPP - Apoptotic specific regulator of p53 | 2005 | 13 | 20 | 60% |
| iASPP: A Novel Protein Involved in Pituitary Tumorigenesis? | 2010 | 3 | 19 | 53% |
| iASPP inhibition: Increased options in targeting the p53 family for cancer therapy | 2008 | 22 | 19 | 26% |
| Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy | 2014 | 1 | 62 | 24% |
| Recent Candidate Molecular Markers: Vitamin D Signaling and Apoptosis Specific Regulator of p53 (ASPP) in Breast Cancer | 2012 | 3 | 57 | 33% |
| To die or not to die: how does p53 decide? | 2004 | 172 | 107 | 5% |
| Update on The Big C: complexity and cross-talk between pathways - Editorial overview | 2002 | 1 | 8 | 13% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HEMATOL ONCOL RHEUMATOL IMMUNOL PULMOL | 3 | 57% | 2.6% | 4 |
| 2 | GUANGXI CANC HOSP | 1 | 30% | 1.9% | 3 |
| 3 | LUDWIG CANC LTD | 1 | 11% | 5.8% | 9 |
| 4 | CANC AREA CELL THER Y | 1 | 50% | 0.6% | 1 |
| 5 | DWR | 1 | 50% | 0.6% | 1 |
| 6 | HENRY WELLCOME TRUST HUMAN GENET | 1 | 50% | 0.6% | 1 |
| 7 | YUNNAN ANIM REPROD BIOL | 0 | 33% | 0.6% | 1 |
| 8 | GLASGOW CANC | 0 | 25% | 0.6% | 1 |
| 9 | LIM14 | 0 | 25% | 0.6% | 1 |
| 10 | MICROARRAY IL TUBINGEN | 0 | 25% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000148239 | MDM2//MDMX//NUTLIN 3 |
| 2 | 0.0000116800 | P73//P63//DELTA NP73 |
| 3 | 0.0000085515 | HIPPO PATHWAY//YAP//HIPPO |
| 4 | 0.0000083453 | TIP30//EASTERN HOSP HEPATOBILIARY SURG//CC3 |
| 5 | 0.0000066454 | NUCLEOSTEMIN//GNL3L//ALKEK BIOSCI TECHNOL |
| 6 | 0.0000059884 | P53 GENE//P53 MUTANTS//MUTANT P53 |
| 7 | 0.0000050464 | BCL2L12//BCL2 FAMILY//G P ANICOLAOU ONCOL |
| 8 | 0.0000048613 | P53 CODON 72//P53 POLYMORPHISM//CODON 72 POLYMORPHISM |
| 9 | 0.0000047650 | TAT BH4//MOL CELLULAR SIGNALING//BIOEMERGENCES IBISA |
| 10 | 0.0000045780 | HIPK2//CACYBP SIP//CACYBP |